ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Clinical Research Program Announcement

February 13, 1981

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

NCCS Networker Volume 4 Issue 3, Summer 1990

June 13, 1990

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980